Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Thriva
At-home blood testing
Remote monitoring & telehealth
London at-home blood testing service that lets patients monitor cholesterol, hormones and other biomarkers via finger-prick kits, with results reviewed against partner-lab accreditation.
The read
Thriva sends finger-prick blood test kits direct to consumers, processes samples through UKAS-accredited partner labs, and returns results with GP-style commentary through its app, covering markers such as cholesterol, thyroid function and vitamin levels. It has positioned itself as a proactive-health monitoring service rather than a diagnostic replacement for GP care.
The company holds ISO 13485 medical-device quality certification, achieved in 2022, and has scaled primarily through consumer subscriptions and employer/insurer health-benefit partnerships rather than NHS commissioning.
The Bridgehead view
Thriva's consumer-subscription model, rather than NHS procurement, means its growth story runs on retention and repeat-testing economics more than the trust-by-trust sales cycle that defines most of this index, worth remembering when comparing its scale claims to NHS-commissioned peers.
Work with us
Working across the healthcare sector?
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
The firm that knows medtech
We map this sector because
we represent it.
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.
